Selected research
Market Analysis & Forecast
Global Pathology Testing Services Market Analysis and Forecast 2026-2032
Market perspective
The global Pathology Testing Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Pathology Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Pathology Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Pathology Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Pathology Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Pathology Testing Services include Quest Diagnostics, BML, Dianon, Pathology Laboratories, Experimental Pathology Laboratories,Inc., PathAI, Randox Health, ACE Laboratory Services and Clinical Labs, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pathology Testing Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pathology Testing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Pathology Testing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pathology Testing Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pathology Testing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pathology Testing Services revenue, projected growth trends, production technology, application and end-user industry.
Pathology Testing Services Segment by Company
Quest Diagnostics
BML
Dianon
Pathology Laboratories
Experimental Pathology Laboratories,Inc.
PathAI
Randox Health
ACE Laboratory Services
Clinical Labs
SYNLAB UK & Ireland
Metropolis Healthcare Ltd.
Acupath Laboratories
Clinipath (Malaysia) Sdn Bhd
QML Pathology Vetnostics
Confluence Health
MPS Ltd
Quest Diagnostics Newsroom
Targos
Sonic Healthcare Limited
Pathology Testing Services Segment by Type
Histopathological Examination
Cytopathological Examination
Molecular Pathology Examination
Pathology Testing Services Segment by Application
Hospital
Clinic
Research Institutions
Pathology Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathology Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pathology Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathology Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pathology Testing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pathology Testing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pathology Testing Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Histopathological Examination
- Cytopathological Examination
- Molecular Pathology Examination
Applications
- Hospital
- Clinic
- Research Institutions
Companies covered
- Quest Diagnostics
- BML
- Dianon
- Pathology Laboratories
- Experimental Pathology Laboratories,Inc.
- PathAI
- Randox Health
- ACE Laboratory Services
- Clinical Labs
- SYNLAB UK & Ireland
- Metropolis Healthcare Ltd.
- Acupath Laboratories
- Clinipath (Malaysia) Sdn Bhd
- QML Pathology Vetnostics
- Confluence Health
- MPS Ltd
- Quest Diagnostics Newsroom
- Targos
- Sonic Healthcare Limited
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pathology Testing Services Market by Type
- 1.2.1 Global Pathology Testing Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Histopathological Examination
- 1.2.3 Cytopathological Examination
- 1.2.4 Molecular Pathology Examination
- 1.3 Pathology Testing Services Market by Application
- 1.3.1 Global Pathology Testing Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Research Institutions
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pathology Testing Services Market Dynamics
- 2.1 Pathology Testing Services Industry Trends
- 2.2 Pathology Testing Services Industry Drivers
- 2.3 Pathology Testing Services Industry Opportunities and Challenges
- 2.4 Pathology Testing Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Pathology Testing Services Market Perspective (2021-2032)
- 3.2 Global Pathology Testing Services Growth Trends by Region
- 3.2.1 Global Pathology Testing Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pathology Testing Services Market Size by Region (2021-2026)
- 3.2.3 Global Pathology Testing Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Pathology Testing Services Revenue by Players
- 4.1.1 Global Pathology Testing Services Revenue by Players (2021-2026)
- 4.1.2 Global Pathology Testing Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Pathology Testing Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pathology Testing Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Pathology Testing Services Key Players Headquarters & Area Served
- 4.4 Global Pathology Testing Services Players, Product Type & Application
- 4.5 Global Pathology Testing Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Pathology Testing Services Market CR5 and HHI
- 4.6.3 2025 Pathology Testing Services Tier 1, Tier 2, and Tier 3
5 Pathology Testing Services Market Size by Type
- 5.1 Global Pathology Testing Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Pathology Testing Services Revenue by Type (2021-2032)
- 5.3 Global Pathology Testing Services Revenue Market Share by Type (2021-2032)
6 Pathology Testing Services Market Size by Application
- 6.1 Global Pathology Testing Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Pathology Testing Services Revenue by Application (2021-2032)
- 6.3 Global Pathology Testing Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Quest Diagnostics
- 7.1.1 Quest Diagnostics Company Information
- 7.1.2 Quest Diagnostics Business Overview
- 7.1.3 Quest Diagnostics Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Quest Diagnostics Pathology Testing Services Product Portfolio
- 7.1.5 Quest Diagnostics Recent Developments
- 7.2 BML
- 7.2.1 BML Company Information
- 7.2.2 BML Business Overview
- 7.2.3 BML Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.2.4 BML Pathology Testing Services Product Portfolio
- 7.2.5 BML Recent Developments
- 7.3 Dianon
- 7.3.1 Dianon Company Information
- 7.3.2 Dianon Business Overview
- 7.3.3 Dianon Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.3.4 Dianon Pathology Testing Services Product Portfolio
- 7.3.5 Dianon Recent Developments
- 7.4 Pathology Laboratories
- 7.4.1 Pathology Laboratories Company Information
- 7.4.2 Pathology Laboratories Business Overview
- 7.4.3 Pathology Laboratories Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.4.4 Pathology Laboratories Pathology Testing Services Product Portfolio
- 7.4.5 Pathology Laboratories Recent Developments
- 7.5 Experimental Pathology Laboratories,Inc.
- 7.5.1 Experimental Pathology Laboratories,Inc. Company Information
- 7.5.2 Experimental Pathology Laboratories,Inc. Business Overview
- 7.5.3 Experimental Pathology Laboratories,Inc. Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.5.4 Experimental Pathology Laboratories,Inc. Pathology Testing Services Product Portfolio
- 7.5.5 Experimental Pathology Laboratories,Inc. Recent Developments
- 7.6 PathAI
- 7.6.1 PathAI Company Information
- 7.6.2 PathAI Business Overview
- 7.6.3 PathAI Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.6.4 PathAI Pathology Testing Services Product Portfolio
- 7.6.5 PathAI Recent Developments
- 7.7 Randox Health
- 7.7.1 Randox Health Company Information
- 7.7.2 Randox Health Business Overview
- 7.7.3 Randox Health Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.7.4 Randox Health Pathology Testing Services Product Portfolio
- 7.7.5 Randox Health Recent Developments
- 7.8 ACE Laboratory Services
- 7.8.1 ACE Laboratory Services Company Information
- 7.8.2 ACE Laboratory Services Business Overview
- 7.8.3 ACE Laboratory Services Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.8.4 ACE Laboratory Services Pathology Testing Services Product Portfolio
- 7.8.5 ACE Laboratory Services Recent Developments
- 7.9 Clinical Labs
- 7.9.1 Clinical Labs Company Information
- 7.9.2 Clinical Labs Business Overview
- 7.9.3 Clinical Labs Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Clinical Labs Pathology Testing Services Product Portfolio
- 7.9.5 Clinical Labs Recent Developments
- 7.10 SYNLAB UK & Ireland
- 7.10.1 SYNLAB UK & Ireland Company Information
- 7.10.2 SYNLAB UK & Ireland Business Overview
- 7.10.3 SYNLAB UK & Ireland Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.10.4 SYNLAB UK & Ireland Pathology Testing Services Product Portfolio
- 7.10.5 SYNLAB UK & Ireland Recent Developments
- 7.11 Metropolis Healthcare Ltd.
- 7.11.1 Metropolis Healthcare Ltd. Company Information
- 7.11.2 Metropolis Healthcare Ltd. Business Overview
- 7.11.3 Metropolis Healthcare Ltd. Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.11.4 Metropolis Healthcare Ltd. Pathology Testing Services Product Portfolio
- 7.11.5 Metropolis Healthcare Ltd. Recent Developments
- 7.12 Acupath Laboratories
- 7.12.1 Acupath Laboratories Company Information
- 7.12.2 Acupath Laboratories Business Overview
- 7.12.3 Acupath Laboratories Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.12.4 Acupath Laboratories Pathology Testing Services Product Portfolio
- 7.12.5 Acupath Laboratories Recent Developments
- 7.13 Clinipath (Malaysia) Sdn Bhd
- 7.13.1 Clinipath (Malaysia) Sdn Bhd Company Information
- 7.13.2 Clinipath (Malaysia) Sdn Bhd Business Overview
- 7.13.3 Clinipath (Malaysia) Sdn Bhd Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.13.4 Clinipath (Malaysia) Sdn Bhd Pathology Testing Services Product Portfolio
- 7.13.5 Clinipath (Malaysia) Sdn Bhd Recent Developments
- 7.14 QML Pathology Vetnostics
- 7.14.1 QML Pathology Vetnostics Company Information
- 7.14.2 QML Pathology Vetnostics Business Overview
- 7.14.3 QML Pathology Vetnostics Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.14.4 QML Pathology Vetnostics Pathology Testing Services Product Portfolio
- 7.14.5 QML Pathology Vetnostics Recent Developments
- 7.15 Confluence Health
- 7.15.1 Confluence Health Company Information
- 7.15.2 Confluence Health Business Overview
- 7.15.3 Confluence Health Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.15.4 Confluence Health Pathology Testing Services Product Portfolio
- 7.15.5 Confluence Health Recent Developments
- 7.16 MPS Ltd
- 7.16.1 MPS Ltd Company Information
- 7.16.2 MPS Ltd Business Overview
- 7.16.3 MPS Ltd Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.16.4 MPS Ltd Pathology Testing Services Product Portfolio
- 7.16.5 MPS Ltd Recent Developments
- 7.17 Quest Diagnostics Newsroom
- 7.17.1 Quest Diagnostics Newsroom Company Information
- 7.17.2 Quest Diagnostics Newsroom Business Overview
- 7.17.3 Quest Diagnostics Newsroom Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.17.4 Quest Diagnostics Newsroom Pathology Testing Services Product Portfolio
- 7.17.5 Quest Diagnostics Newsroom Recent Developments
- 7.18 Targos
- 7.18.1 Targos Company Information
- 7.18.2 Targos Business Overview
- 7.18.3 Targos Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.18.4 Targos Pathology Testing Services Product Portfolio
- 7.18.5 Targos Recent Developments
- 7.19 Sonic Healthcare Limited
- 7.19.1 Sonic Healthcare Limited Company Information
- 7.19.2 Sonic Healthcare Limited Business Overview
- 7.19.3 Sonic Healthcare Limited Pathology Testing Services Revenue and Gross Margin (2021-2026)
- 7.19.4 Sonic Healthcare Limited Pathology Testing Services Product Portfolio
- 7.19.5 Sonic Healthcare Limited Recent Developments
8 North America
- 8.1 North America Pathology Testing Services Revenue (2021-2032)
- 8.2 North America Pathology Testing Services Revenue by Type (2021-2032)
- 8.2.1 North America Pathology Testing Services Revenue by Type (2021-2026)
- 8.2.2 North America Pathology Testing Services Revenue by Type (2027-2032)
- 8.3 North America Pathology Testing Services Revenue Share by Type (2021-2032)
- 8.4 North America Pathology Testing Services Revenue by Application (2021-2032)
- 8.4.1 North America Pathology Testing Services Revenue by Application (2021-2026)
- 8.4.2 North America Pathology Testing Services Revenue by Application (2027-2032)
- 8.5 North America Pathology Testing Services Revenue Share by Application (2021-2032)
- 8.6 North America Pathology Testing Services Revenue by Country
- 8.6.1 North America Pathology Testing Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Pathology Testing Services Revenue by Country (2021-2026)
- 8.6.3 North America Pathology Testing Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Pathology Testing Services Revenue (2021-2032)
- 9.2 Europe Pathology Testing Services Revenue by Type (2021-2032)
- 9.2.1 Europe Pathology Testing Services Revenue by Type (2021-2026)
- 9.2.2 Europe Pathology Testing Services Revenue by Type (2027-2032)
- 9.3 Europe Pathology Testing Services Revenue Share by Type (2021-2032)
- 9.4 Europe Pathology Testing Services Revenue by Application (2021-2032)
- 9.4.1 Europe Pathology Testing Services Revenue by Application (2021-2026)
- 9.4.2 Europe Pathology Testing Services Revenue by Application (2027-2032)
- 9.5 Europe Pathology Testing Services Revenue Share by Application (2021-2032)
- 9.6 Europe Pathology Testing Services Revenue by Country
- 9.6.1 Europe Pathology Testing Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Pathology Testing Services Revenue by Country (2021-2026)
- 9.6.3 Europe Pathology Testing Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Pathology Testing Services Revenue (2021-2032)
- 10.2 China Pathology Testing Services Revenue by Type (2021-2032)
- 10.2.1 China Pathology Testing Services Revenue by Type (2021-2026)
- 10.2.2 China Pathology Testing Services Revenue by Type (2027-2032)
- 10.3 China Pathology Testing Services Revenue Share by Type (2021-2032)
- 10.4 China Pathology Testing Services Revenue by Application (2021-2032)
- 10.4.1 China Pathology Testing Services Revenue by Application (2021-2026)
- 10.4.2 China Pathology Testing Services Revenue by Application (2027-2032)
- 10.5 China Pathology Testing Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pathology Testing Services Revenue (2021-2032)
- 11.2 Asia Pathology Testing Services Revenue by Type (2021-2032)
- 11.2.1 Asia Pathology Testing Services Revenue by Type (2021-2026)
- 11.2.2 Asia Pathology Testing Services Revenue by Type (2027-2032)
- 11.3 Asia Pathology Testing Services Revenue Share by Type (2021-2032)
- 11.4 Asia Pathology Testing Services Revenue by Application (2021-2032)
- 11.4.1 Asia Pathology Testing Services Revenue by Application (2021-2026)
- 11.4.2 Asia Pathology Testing Services Revenue by Application (2027-2032)
- 11.5 Asia Pathology Testing Services Revenue Share by Application (2021-2032)
- 11.6 Asia Pathology Testing Services Revenue by Country
- 11.6.1 Asia Pathology Testing Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Pathology Testing Services Revenue by Country (2021-2026)
- 11.6.3 Asia Pathology Testing Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pathology Testing Services Revenue (2021-2032)
- 12.2 SAMEA Pathology Testing Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Pathology Testing Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Pathology Testing Services Revenue by Type (2027-2032)
- 12.3 SAMEA Pathology Testing Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Pathology Testing Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Pathology Testing Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Pathology Testing Services Revenue by Application (2027-2032)
- 12.5 SAMEA Pathology Testing Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Pathology Testing Services Revenue by Country
- 12.6.1 SAMEA Pathology Testing Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Pathology Testing Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Pathology Testing Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst